Sign up for free insights newsletter
60

Yifeng Pharmacy

603939SHG

Need professional-grade analysis? Visit stockanalysis.com

CN¥23.67
-3.19%
End of day
Market Cap

$29.24B

P/E Ratio

18.41

Employees

40,018

Dividend Yield

2.85%

Price Chart

Risk-Adjusted Performance

Ratio1W1M3M6M1Y5YScore
Sortino-0.68-0.30-0.47
Calmar-0.73-0.21-0.44
Sharpe-0.41-0.19-0.29
Omega0.940.990.96
Martin-1.47-0.35-0.85
Ulcer8.4716.0412.67

Yifeng Pharmacy (603939) Price Performance

Yifeng Pharmacy (603939) trades on SHG in CNY. The company is classified in the Healthcare sector under the Pharmaceutical Retailers industry. The stock currently trades at CNY23.67, down 3.19% from the previous close.

Over the past year, 603939 has traded between a low of CNY21.12 and a high of CNY29.06. The stock has lost 4.2% over this period. It is currently 18.5% below its 52-week high.

Yifeng Pharmacy has a market capitalization of $29.24B, with a price-to-earnings ratio of 18.41 and a dividend yield of 2.85%.

About Yifeng Pharmacy

Yifeng Pharmacy Chain Co., Ltd. engages in the retail business of pharmaceutical products in China. The company operates through Retail business and Wholesale business segments. It offers Western and Chinese patent medicine, traditional Chinese medicine herbal pieces, medical devices and equipment, health supplements and products, personal care products, drugs, and convenience products related to health. The company is also involved in chronic disease management, medical project investment, and medical technology development, as well as operates internet hospitals. It also offers its products through franchise distribution and e-commerce. Yifeng Pharmacy Chain Co., Ltd. was founded in 2001 and is headquartered in Changsha, China.

Company Info

Exchange
SHG
Currency
CNY
Country
China

Financial Metrics

Revenue (TTM)
$24.13B
EBITDA
$2.65B
Profit Margin
6.81%
EPS (TTM)
1.31
Book Value
9.22

Technical Indicators

52 Week High
CN¥29.26
52 Week Low
CN¥20.81
50 Day MA
CN¥23.88
200 Day MA
CN¥23.98
Beta
0.63

Valuation

Trailing P/E
18.41
Forward P/E
N/A
Price/Sales
1.21
Price/Book
2.66
Enterprise Value
$26.32B